Literature DB >> 25359708

Increased expression of T cell immunoglobulin and mucin domain 4 is positively associated with the disease severity of patients with ankylosing spondylitis.

Dongdong Chen1, Jianying He, Changchang Lu, Jihang Zhou, Kexin Fang, Xiaoguang Liu, Liyun Xu.   

Abstract

Monocytes and associated cytokines have been shown to be involved in the pathogenesis of ankylosing spondylitis (AS). T cell immunoglobulin and mucin domain 4 (Tim-4) was identified on monocytes/macrophages and dentritic cells (DCs) and plays important roles in regulating the activities of macrophages and DCs. The current study investigated the association between Tim-4 expression and AS. Our results showed that Tim-4 expression on monocytes and Tim-4 level in plasma were highly increased in AS patients than in controls. Furthermore, TNF-α production and bath ankylosing spondylitis disease activity index (BASDAI) have positive relationships with Tim-4 expression in AS patients. High expression of Tim-4 was thought to contribute to the pathogenesis and an underlying mechanism of AS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25359708     DOI: 10.1007/s10753-014-0055-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  20 in total

1.  TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells.

Authors:  Lee A Albacker; Piia Karisola; Ya-Jen Chang; Sarah E Umetsu; Meixia Zhou; Omid Akbari; Norimoto Kobayashi; Nicole Baumgarth; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

2.  TIM-1 induces T cell activation and inhibits the development of peripheral tolerance.

Authors:  Sarah E Umetsu; Wan-Ling Lee; Jennifer J McIntire; Laura Downey; Bharati Sanjanwala; Omid Akbari; Gerald J Berry; Haruo Nagumo; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Nat Immunol       Date:  2005-03-27       Impact factor: 25.606

3.  Genome wide gene expression analysis of macrophages from ankylosing spondylitis patients under interferon-gamma treatment.

Authors:  H Ma; B Ye; Q Wei; X D Zhu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-10       Impact factor: 3.507

Review 4.  Quality of life in patients with ankylosing spondylitis.

Authors:  M M Ward
Journal:  Rheum Dis Clin North Am       Date:  1998-11       Impact factor: 2.670

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

Review 6.  Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory?

Authors:  Carmen Ambarus; Nataliya Yeremenko; Paul P Tak; Dominique Baeten
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

Review 7.  The TIM gene family: emerging roles in immunity and disease.

Authors:  Vijay K Kuchroo; Dale T Umetsu; Rosemarie H DeKruyff; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

8.  TIM-4 has dual function in the induction and effector phases of murine arthritis.

Authors:  Yoshiyuki Abe; Fumitaka Kamachi; Toshio Kawamoto; Fumihiko Makino; Jun Ito; Yuko Kojima; Alaa El Din Hussein Moustapha; Yoshihiko Usui; Hideo Yagita; Yoshinari Takasaki; Ko Okumura; Hisaya Akiba
Journal:  J Immunol       Date:  2013-09-25       Impact factor: 5.422

9.  T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis.

Authors:  Mohsen Khademi; Zsolt Illés; Alexander W Gielen; Monica Marta; Naruhiko Takazawa; Claire Baecher-Allan; Lou Brundin; Jan Hannerz; Claes Martin; Robert A Harris; David A Hafler; Vijay K Kuchroo; Tomas Olsson; Fredrik Piehl; Erik Wallström
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

10.  Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients.

Authors:  Y Wang; J Meng; X Wang; S Liu; Q Shu; L Gao; Y Ju; L Zhang; W Sun; C Ma
Journal:  Scand J Immunol       Date:  2008-01       Impact factor: 3.487

View more
  3 in total

Review 1.  Expression and Metabolomic Profiling in Axial Spondyloarthritis.

Authors:  Darren D O'Rielly; Guangju Zhai; Proton Rahman
Journal:  Curr Rheumatol Rep       Date:  2018-06-27       Impact factor: 4.592

2.  Expression and function of Toll‑like receptors in peripheral blood mononuclear cells in patients with ankylosing spondylitis.

Authors:  Jun Zhang; Rongming Xu; Lei Wu; Jihong Jiang
Journal:  Mol Med Rep       Date:  2019-09-02       Impact factor: 2.952

Review 3.  Tim-4 in Health and Disease: Friend or Foe?

Authors:  Wen Liu; Liyun Xu; Xiaohong Liang; Xiaojun Liu; Yangbing Zhao; Chunhong Ma; Lifen Gao
Journal:  Front Immunol       Date:  2020-04-02       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.